Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126339541 | 12633954 | 1 | I | 2007 | 20160802 | 20160809 | 20160809 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-50655BP | BOEHRINGER INGELHEIM | 45.16 | YR | F | Y | 0.00000 | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126339541 | 12633954 | 1 | PS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 601156A | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | |||||
| 126339541 | 12633954 | 2 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Oral | 18 MCG | 601156A | 21395 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD | |||||
| 126339541 | 12633954 | 3 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 2 ANZ | 0 | NEBULISER LIQUID | BID | ||||||||
| 126339541 | 12633954 | 4 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 1 ANZ | 0 | NEBULISER LIQUID | QD | ||||||||
| 126339541 | 12633954 | 5 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 1 ANZ | 0 | ORAL SOLUTION | |||||||||
| 126339541 | 12633954 | 6 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 2 ANZ | 0 | TABLET | BID | ||||||||
| 126339541 | 12633954 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD | ||||||
| 126339541 | 12633954 | 8 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 10 MG | 0 | 10 | MG | TABLET | QD | ||||||
| 126339541 | 12633954 | 9 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | Oral | 1 ANZ | 0 | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126339541 | 12633954 | 1 | Asthma |
| 126339541 | 12633954 | 3 | Asthma |
| 126339541 | 12633954 | 4 | Asthma |
| 126339541 | 12633954 | 6 | Anxiety |
| 126339541 | 12633954 | 7 | Hypertension |
| 126339541 | 12633954 | 8 | Endometriosis |
| 126339541 | 12633954 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126339541 | 12633954 | HO |
| 126339541 | 12633954 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126339541 | 12633954 | Asthma | |
| 126339541 | 12633954 | Incorrect route of drug administration | |
| 126339541 | 12633954 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126339541 | 12633954 | 1 | 2007 | 0 | ||
| 126339541 | 12633954 | 2 | 20160802 | 20160802 | 0 | |
| 126339541 | 12633954 | 3 | 2006 | 0 |